Advertisements
Advertisement

Q4 results: Laurus Labs#39; PAT increases by 39% to Rs 74.3-cr

Q4 results: Laurus Labs#39; PAT increases by 39% to Rs 74.3-cr.....»»

Category:finance~latestSource:  moneycontrolMay 19th, 2017


Laurus Labs PAT Grows by 40%; Board Recommends a Dividend of 15%

Laurus Labs PAT Grows by 40%; Board Recommends a Dividend of 15%.....»»

Category: finance~press-releasesSource:  businesswireindiaRelated NewsMay 19th, 2017

Norges Bank sells 5.67 lakh shares of Laurus Labs

Norges Bank sells 5.67 lakh shares of Laurus Labs.....»»

Category: finance~latestSource:  moneycontrolRelated NewsApr 8th, 2017

Hike in minimum import price boosts domestic market for arecanut

Hike in minimum import price boosts domestic market for arecanut.....»»

Category: finance~latestSource:  businesslineRelated NewsApr 5th, 2017

Laurus Labs director Frank J Wright resigns

Laurus Labs director Frank J Wright resigns.....»»

Category: finance~latestSource:  moneycontrolRelated NewsMar 27th, 2017

Midcap pharma stocks could be a worthwhile bet

Midcap pharma stocks could be a worthwhile bet.....»»

Category: finance~marketSource:  theeconomictimesRelated NewsMar 16th, 2017

UP Election Results 2017: Modi wave helps BJP win 312 seats; increases vote share by 25%

UP Election Results 2017: Modi wave helps BJP win 312 seats; increases vote share by 25%.....»»

Category: news~latestSource:  firstpostRelated NewsMar 11th, 2017

Sensex ends rangebound session flat ahead of exit poll results

Sensex ends rangebound session flat ahead of exit poll results.....»»

Category: finance~latestSource:  moneycontrolRelated NewsMar 9th, 2017

Will Pick A Coach Who Wins Matches, Says Sourav Ganguly

Will Pick A Coach Who Wins Matches, Says Sourav Ganguly.....»»

Category: sports~latestSource:  ndtvRelated News19 hr. 27 min. ago

Google now scrubbing private medical records from search results

Google now scrubbing private medical records from search results.....»»

Category: finance~latestSource:  livemintRelated NewsJun 23rd, 2017

India faces acute shortage of yoga instructors

India faces acute shortage of yoga instructors.....»»

Category: movies~kollywoodSource:  indiaglitzRelated NewsJun 21st, 2017

Anil Kumble Delivered Results. Can Anyone Challenge That?: Bishen Singh Bedi

Anil Kumble Delivered Results. Can Anyone Challenge That?: Bishen Singh Bedi.....»»

Category: sports~latestSource:  ndtvRelated NewsJun 21st, 2017

Niti Aayog to set up 1,000 more innovation labs this year

Niti Aayog to set up 1,000 more innovation labs this year.....»»

Category: news~Source:  eenaduindiaRelated NewsJun 16th, 2017

India-Born Arun Netravali, Former Bell Labs President and Digital Video Pioneer, Awarded the 2017 Marconi Prize

India-Born Arun Netravali, Former Bell Labs President and Digital Video Pioneer, Awarded the 2017 Marconi Prize.....»»

Category: finance~press-releasesSource:  businesswireindiaRelated NewsJun 16th, 2017

US Federal Reserve increases rate by 25 bps

US Federal Reserve increases rate by 25 bps.....»»

Category: finance~latestSource:  businesslineRelated NewsJun 15th, 2017

AIIMS declares MBBS entrance test results

AIIMS declares MBBS entrance test results.....»»

Category: finance~latestSource:  businesslineRelated NewsJun 15th, 2017

Many from Bengaluru in top 100 of AIIMS rank list

Many from Bengaluru in top 100 of AIIMS rank list.....»»

Category: news~latestSource:  deccanheraldRelated NewsJun 15th, 2017

Top 10 in AIIMS entrance from same coaching institute in Kota

Top 10 in AIIMS entrance from same coaching institute in Kota.....»»

Category: news~latestSource:  deccanheraldRelated NewsJun 15th, 2017

AIIMS MBBS 2017 results announced

AIIMS MBBS 2017 results announced.....»»

Category: news~delhiSource:  thehinduRelated NewsJun 15th, 2017

Badminton: Prannoy and Srikanth advance

Badminton: Prannoy and Srikanth advance.....»»

Category: sports~latestSource:  thehinduRelated NewsJun 14th, 2017

Boehringer Ingelheim presents phase III results demonstrating clinical equivalence of adalimumab biosimilar candidate to HUMIRA®

Boehringer Ingelheim presents phase III results demonstrating clinical equivalence of adalimumab biosimilar candidate to HUMIRA®.....»»

Category: finance~press-releasesSource:  businesswireindiaRelated NewsJun 14th, 2017